{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:52:39Z","timestamp":1791334359080,"version":"4.3.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004480","name":"Natural Science Foundation of Shanxi Province","doi-asserted-by":"publisher","award":["No. 202403021221271"],"award-info":[{"award-number":["No. 202403021221271"]}],"id":[{"id":"10.13039\/501100004480","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004480","name":"Natural Science Foundation of Shanxi Province","doi-asserted-by":"publisher","award":["No.202303021212366"],"award-info":[{"award-number":["No.202303021212366"]}],"id":[{"id":"10.13039\/501100004480","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004480","name":"Natural Science Foundation of Shanxi Province","doi-asserted-by":"publisher","award":["No. 202303021222376"],"award-info":[{"award-number":["No. 202303021222376"]}],"id":[{"id":"10.13039\/501100004480","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanxi Provincial Graduate Education Innovation Program","award":["No.2024SJ157"],"award-info":[{"award-number":["No.2024SJ157"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08621-0","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T09:33:54Z","timestamp":1783762434000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["INHBA secreted by cancer-associated fibroblasts promotes cisplatin resistance and malignant progression of ovarian cancer via ENG-mediated suppression of apoptosis and induction of EMT"],"prefix":"10.1186","volume":"24","author":[{"given":"Xinyue","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichao","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1776-4843","authenticated-orcid":false,"given":"Yuping","family":"Suo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"issue":"1","key":"8621_CR1","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, et al. Cancer statistics, 2025. CA Cancer J Clin. 2025;75(1):10\u201345.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"8621_CR2","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s11010-021-04306-y","volume":"477","author":"S Ahmed","year":"2022","unstructured":"Ahmed S, et al. Therapeutic potential of marine peptides in cervical and ovarian cancers. Mol Cell Biochem. 2022;477(2):605\u201319.","journal-title":"Mol Cell Biochem"},{"issue":"suppl8","key":"8621_CR3","doi-asserted-by":"publisher","first-page":"viii61","DOI":"10.1093\/annonc\/mdx443","volume":"28","author":"EA Eisenhauer","year":"2017","unstructured":"Eisenhauer EA. Real-world evidence in the treatment of ovarian cancer. Ann Oncol. 2017;28(suppl8):viii61\u20135.","journal-title":"Ann Oncol"},{"issue":"10","key":"8621_CR4","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1016\/j.ccell.2024.08.016","volume":"42","author":"E Bayraktar","year":"2024","unstructured":"Bayraktar E, et al. Ovarian cancer metastasis: Looking beyond the surface. Cancer Cell. 2024;42(10):1631\u20136.","journal-title":"Cancer Cell"},{"key":"8621_CR5","doi-asserted-by":"crossref","unstructured":"Ashrafizadeh M, et al. Association of the epithelial-mesenchymal transition (EMT) with cisplatin resistance. Int J Mol Sci. 2020;21(11).","DOI":"10.3390\/ijms21114002"},{"issue":"1","key":"8621_CR6","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1038\/s41598-025-87388-8","volume":"15","author":"TU Wani","year":"2025","unstructured":"Wani TU, et al. Mechanistic insights into epithelial-mesenchymal transition mediated cisplatin resistance in ovarian cancer. Sci Rep. 2025;15(1):3053.","journal-title":"Sci Rep"},{"key":"8621_CR7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.semcancer.2020.12.024","volume":"77","author":"A Ghoneum","year":"2021","unstructured":"Ghoneum A, et al. Exploring the clinical value of tumor microenvironment in platinum-resistant ovarian cancer. Semin Cancer Biol. 2021;77:83\u201398.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"8621_CR8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13048-022-01003-2","volume":"15","author":"L Han","year":"2022","unstructured":"Han L, et al. Identification of key genes and pathways related to cancer-associated fibroblasts in chemoresistance of ovarian cancer cells based on GEO and TCGA databases. J Ovarian Res. 2022;15(1):75.","journal-title":"J Ovarian Res"},{"issue":"8","key":"8621_CR9","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1093\/annonc\/mdw168","volume":"27","author":"JM Pitt","year":"2016","unstructured":"Pitt JM, et al. Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy. Ann Oncol. 2016;27(8):1482\u201392.","journal-title":"Ann Oncol"},{"issue":"2","key":"8621_CR10","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","volume":"18","author":"X Chen","year":"2019","unstructured":"Chen X, Song E. Turning foes to friends: targeting cancer-associated fibroblasts. Nat Rev Drug Discov. 2019;18(2):99\u2013115.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"8621_CR11","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12943-023-01876-x","volume":"22","author":"C Ma","year":"2023","unstructured":"Ma C, et al. Pan-cancer spatially resolved single-cell analysis reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment. Mol Cancer. 2023;22(1):170.","journal-title":"Mol Cancer"},{"key":"8621_CR12","doi-asserted-by":"crossref","unstructured":"Zhang M, et al. The role of cancer-associated fibroblasts in ovarian cancer. Cancers (Basel). 2022;14(11).","DOI":"10.3390\/cancers14112637"},{"key":"8621_CR13","doi-asserted-by":"publisher","first-page":"1504762","DOI":"10.3389\/fonc.2025.1504762","volume":"15","author":"Y Xu","year":"2025","unstructured":"Xu Y, et al. Cancer-associated fibroblasts in ovarian cancer: research progress. Front Oncol. 2025;15:1504762.","journal-title":"Front Oncol"},{"key":"8621_CR14","doi-asserted-by":"crossref","unstructured":"Papait A, et al. Fight the cancer, hit the CAF! Cancers (Basel). 2022;14(15).","DOI":"10.3390\/cancers14153570"},{"issue":"12","key":"8621_CR15","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s41571-021-00546-5","volume":"18","author":"Y Chen","year":"2021","unstructured":"Chen Y, McAndrews KM, Kalluri R. Clinical and therapeutic relevance of cancer-associated fibroblasts. Nat Rev Clin Oncol. 2021;18(12):792\u2013804.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"8621_CR16","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1152\/physrev.00048.2019","volume":"101","author":"G Biffi","year":"2021","unstructured":"Biffi G, Tuveson DA. Diversity and Biology of Cancer-Associated Fibroblasts. Physiol Rev. 2021;101(1):147\u201376.","journal-title":"Physiol Rev"},{"issue":"2","key":"8621_CR17","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.tem.2005.01.003","volume":"16","author":"CA Harrison","year":"2005","unstructured":"Harrison CA, et al. Antagonists of activin signaling: mechanisms and potential biological applications. Trends Endocrinol Metab. 2005;16(2):73\u20138.","journal-title":"Trends Endocrinol Metab"},{"issue":"4","key":"8621_CR18","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1593\/neo.81582","volume":"11","author":"CW Seder","year":"2009","unstructured":"Seder CW, et al. Upregulated INHBA expression may promote cell proliferation and is associated with poor survival in lung adenocarcinoma. Neoplasia. 2009;11(4):388\u201396.","journal-title":"Neoplasia"},{"issue":"1","key":"8621_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41698-024-00523-y","volume":"8","author":"Y Hu","year":"2024","unstructured":"Hu Y, et al. INHBA(+) cancer-associated fibroblasts generate an immunosuppressive tumor microenvironment in ovarian cancer. NPJ Precis Oncol. 2024;8(1):35.","journal-title":"NPJ Precis Oncol"},{"key":"8621_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1755-8794-3-51","volume":"3","author":"H Kim","year":"2010","unstructured":"Kim H, et al. Multi-cancer computational analysis reveals invasion-associated variant of desmoplastic reaction involving INHBA, THBS2 and COL11A1. BMC Med Genomics. 2010;3:51.","journal-title":"BMC Med Genomics"},{"key":"8621_CR21","doi-asserted-by":"publisher","first-page":"p7275289","DOI":"10.1155\/2019\/7275289","volume":"2019","author":"X Li","year":"2019","unstructured":"Li X, et al. Targeting INHBA in Ovarian Cancer Cells Suppresses Cancer Xenograft Growth by Attenuating Stromal Fibroblast Activation. Dis Markers. 2019;2019:p7275289.","journal-title":"Dis Markers"},{"issue":"3","key":"8621_CR22","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA. The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41(3):374\u2013403.","journal-title":"Cancer Cell"},{"key":"8621_CR23","doi-asserted-by":"crossref","unstructured":"Bai S, et al. CD105 is expressed in ovarian cancer precursor lesions and is required for metastasis to the ovary. Cancers (Basel). 2019;11(11).","DOI":"10.3390\/cancers11111710"},{"issue":"3","key":"8621_CR24","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s13277-011-0157-6","volume":"32","author":"AJ Bock","year":"2011","unstructured":"Bock AJ, et al. Endoglin (CD105) expression in ovarian serous carcinoma effusions is related to chemotherapy status. Tumour Biol. 2011;32(3):589\u201396.","journal-title":"Tumour Biol"},{"issue":"4","key":"8621_CR25","doi-asserted-by":"publisher","first-page":"115555","DOI":"10.1016\/j.celrep.2025.115555","volume":"44","author":"Z Liu","year":"2025","unstructured":"Liu Z, et al. THBS2-producing matrix CAFs promote colorectal cancer progression and link to poor prognosis via the CD47-MAPK axis. Cell Rep. 2025;44(4):115555.","journal-title":"Cell Rep"},{"key":"8621_CR26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13059-016-0929-9","volume":"17","author":"EM Ross","year":"2016","unstructured":"Ross EM, Markowetz F. OncoNEM: inferring tumor evolution from single-cell sequencing data. Genome Biol. 2016;17:69.","journal-title":"Genome Biol"},{"issue":"8016","key":"8621_CR27","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson J, et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature. 2024;630(8016):493\u2013500.","journal-title":"Nature"},{"issue":"4","key":"8621_CR28","doi-asserted-by":"publisher","first-page":"152292","DOI":"10.1016\/j.acthis.2025.152292","volume":"127","author":"M Zhang","year":"2025","unstructured":"Zhang M, et al. Cancer-associated fibroblast-derived CCL5 enhanced aerobic glycolysis through upregulation of IP3R to promote breast cancer cell metastasis. Acta Histochem. 2025;127(4):152292.","journal-title":"Acta Histochem"},{"key":"8621_CR29","doi-asserted-by":"publisher","first-page":"120240","DOI":"10.1016\/j.jep.2025.120240","volume":"352","author":"C He","year":"2025","unstructured":"He C, et al. Xiaoji decoction induces apoptosis in lung cancer cells and M1 Macrophage polarization via the JAK1\/STAT3\/PD-L1 pathway. J Ethnopharmacol. 2025;352:120240.","journal-title":"J Ethnopharmacol"},{"key":"8621_CR30","doi-asserted-by":"crossref","unstructured":"Li Y, et al. Cancer-associated fibroblasts hinder lung squamous cell carcinoma oxidative stress-induced apoptosis via METTL3-mediated m(6)A methylation of COL10A1. Oxid Med Cell Longev. 2022;2022:4320809.","DOI":"10.1155\/2022\/4320809"},{"issue":"1","key":"8621_CR31","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s13046-018-0908-y","volume":"37","author":"Q Li","year":"2018","unstructured":"Li Q, et al. HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK\/ERK and PI3K\/AKT signaling pathways. J Exp Clin Cancer Res. 2018;37(1):231.","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"8621_CR32","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/s41419-024-06816-1","volume":"15","author":"X Luo","year":"2024","unstructured":"Luo X, et al. CSTF3 contributes to platinum resistance in ovarian cancer through alternative polyadenylation of lncRNA NEAT1 and generating the short isoform NEAT1_1. Cell Death Dis. 2024;15(6):432.","journal-title":"Cell Death Dis"},{"key":"8621_CR33","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3389\/fonc.2014.00062","volume":"4","author":"M Augsten","year":"2014","unstructured":"Augsten M. Cancer-associated fibroblasts as another polarized cell type of the tumor microenvironment. Front Oncol. 2014;4:62.","journal-title":"Front Oncol"},{"key":"8621_CR34","doi-asserted-by":"publisher","first-page":"113697","DOI":"10.1016\/j.intimp.2024.113697","volume":"144","author":"T Liu","year":"2025","unstructured":"Liu T, et al. FAP(+) gastric cancer mesenchymal stromal cells via paracrining INHBA and remodeling ECM promote tumor progression. Int Immunopharmacol. 2025;144:113697.","journal-title":"Int Immunopharmacol"},{"key":"8621_CR35","doi-asserted-by":"publisher","first-page":"5905","DOI":"10.2147\/DDDT.S487371","volume":"18","author":"L Liang","year":"2024","unstructured":"Liang L, et al. Zuojin Pill Alleviates Precancerous Lesions of Gastric Cancer by Modulating the MEK\/ERK\/c-Myc Pathway: An Integrated Approach of Network Pharmacology, Molecular Dynamics Simulation, and Experimental Validation. Drug Des Devel Ther. 2024;18:5905\u201329.","journal-title":"Drug Des Devel Ther"},{"issue":"W1","key":"8621_CR36","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98\u2013102.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"8621_CR37","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13058-016-0740-2","volume":"18","author":"KM Bussard","year":"2016","unstructured":"Bussard KM, et al. Tumor-associated stromal cells as key contributors to the tumor microenvironment. Breast Cancer Res. 2016;18(1):84.","journal-title":"Breast Cancer Res"},{"issue":"728","key":"8621_CR38","doi-asserted-by":"publisher","first-page":"eadg3840","DOI":"10.1126\/scitranslmed.adg3840","volume":"16","author":"JJF Sleeboom","year":"2024","unstructured":"Sleeboom JJF, et al. The extracellular matrix as hallmark of cancer and metastasis: From biomechanics to therapeutic targets. Sci Transl Med. 2024;16(728):eadg3840.","journal-title":"Sci Transl Med"},{"issue":"26","key":"8621_CR39","doi-asserted-by":"publisher","first-page":"4503","DOI":"10.1038\/s41388-021-01865-8","volume":"40","author":"YH Wu","year":"2021","unstructured":"Wu YH, et al. COL11A1 activates cancer-associated fibroblasts by modulating TGF-\u03b23 through the NF-\u03baB\/IGFBP2 axis in ovarian cancer cells. Oncogene. 2021;40(26):4503\u201319.","journal-title":"Oncogene"},{"key":"8621_CR40","doi-asserted-by":"publisher","first-page":"216700","DOI":"10.1016\/j.canlet.2024.216700","volume":"588","author":"J Liu","year":"2024","unstructured":"Liu J, et al. STING inhibitors sensitize platinum chemotherapy in ovarian cancer by inhibiting the CGAS-STING pathway in cancer-associated fibroblasts (CAFs). Cancer Lett. 2024;588:216700.","journal-title":"Cancer Lett"},{"issue":"5","key":"8621_CR41","first-page":"2081","volume":"39","author":"L Wang","year":"2018","unstructured":"Wang L, et al. CAFs enhance paclitaxel resistance by inducing EMT through the IL\u20136\/JAK2\/STAT3 pathway. Oncol Rep. 2018;39(5):2081\u201390.","journal-title":"Oncol Rep"},{"issue":"1","key":"8621_CR42","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ccell.2023.12.002","volume":"42","author":"G Mucciolo","year":"2024","unstructured":"Mucciolo G, et al. EGFR-activated myofibroblasts promote metastasis of pancreatic cancer. Cancer Cell. 2024;42(1):101\u2013e11811.","journal-title":"Cancer Cell"},{"key":"8621_CR43","doi-asserted-by":"crossref","unstructured":"Deying W, et al. CAF-derived HGF promotes cell proliferation and drug resistance by up-regulating the c-Met\/PI3K\/Akt and GRP78 signalling in ovarian cancer cells. Biosci Rep. 2017;37(2).","DOI":"10.1042\/BSR20160470"},{"issue":"1","key":"8621_CR44","doi-asserted-by":"publisher","first-page":"6315","DOI":"10.1038\/s41467-020-19920-5","volume":"11","author":"AL Grauel","year":"2020","unstructured":"Grauel AL, et al. TGF\u03b2-blockade uncovers stromal plasticity in tumors by revealing the existence of a subset of interferon-licensed fibroblasts. Nat Commun. 2020;11(1):6315.","journal-title":"Nat Commun"},{"key":"8621_CR45","doi-asserted-by":"publisher","first-page":"705512","DOI":"10.3389\/fgene.2021.705512","volume":"12","author":"K Zhao","year":"2021","unstructured":"Zhao K, et al. INHBA is a Prognostic Biomarker and Correlated With Immune Cell Infiltration in Cervical Cancer. Front Genet. 2021;12:705512.","journal-title":"Front Genet"},{"key":"8621_CR46","doi-asserted-by":"crossref","unstructured":"Nagaraja AS, et al. Adrenergic-mediated increases in INHBA drive CAF phenotype and collagens. JCI Insight. 2017;2(16).","DOI":"10.1172\/jci.insight.93076"},{"issue":"16","key":"8621_CR47","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1158\/0008-5472.CAN-19-3763","volume":"80","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, et al. Oncogene-Induced Senescence Limits the Progression of Pancreatic Neoplasia through Production of Activin A. Cancer Res. 2020;80(16):3359\u201371.","journal-title":"Cancer Res"},{"issue":"1","key":"8621_CR48","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1186\/s12885-025-14261-2","volume":"25","author":"S Zhao","year":"2025","unstructured":"Zhao S, et al. INHBA(+) macrophages and Pro-inflammatory CAFs are associated with distinctive immunosuppressive tumor microenvironment in submucous Fibrosis-Derived oral squamous cell carcinoma. BMC Cancer. 2025;25(1):857.","journal-title":"BMC Cancer"},{"issue":"12","key":"8621_CR49","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1002\/mc.23615","volume":"62","author":"S Hu","year":"2023","unstructured":"Hu S, et al. Integrated analysis of single cell and bulk RNA sequencing identifies CTHRC1(+) INHBA(+) CAF as drivers of colorectal cancer progression. Mol Carcinog. 2023;62(12):1787\u2013802.","journal-title":"Mol Carcinog"},{"issue":"2","key":"8621_CR50","doi-asserted-by":"publisher","first-page":"620","DOI":"10.7150\/thno.60540","volume":"12","author":"X Li","year":"2022","unstructured":"Li X, et al. Single-cell RNA sequencing reveals a pro-invasive cancer-associated fibroblast subgroup associated with poor clinical outcomes in patients with gastric cancer. Theranostics. 2022;12(2):620\u201338.","journal-title":"Theranostics"},{"key":"8621_CR51","doi-asserted-by":"crossref","unstructured":"Badran O, Cohen I, Bar-Sela G. Cancer-associated fibroblasts in solid tumors and sarcomas: heterogeneity, function, and therapeutic implications. Cells. 2025;14(17).","DOI":"10.3390\/cells14171398"},{"issue":"4","key":"8621_CR52","doi-asserted-by":"publisher","first-page":"e0249558","DOI":"10.1371\/journal.pone.0249558","volume":"16","author":"E Listik","year":"2021","unstructured":"Listik E, et al. A bioinformatic analysis of the inhibin-betaglycan-endoglin\/CD105 network reveals prognostic value in multiple solid tumors. PLoS ONE. 2021;16(4):e0249558.","journal-title":"PLoS ONE"},{"issue":"7579","key":"8621_CR53","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nature16064","volume":"527","author":"X Zheng","year":"2015","unstructured":"Zheng X, et al. Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer. Nature. 2015;527(7579):525\u201330.","journal-title":"Nature"},{"issue":"1","key":"8621_CR54","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1186\/s13018-023-04330-2","volume":"18","author":"H Zhang","year":"2023","unstructured":"Zhang H, et al. INHBA gene silencing inhibits proliferation, migration, and invasion of osteosarcoma cells by repressing TGF-\u03b2 signaling pathway activation. J Orthop Surg Res. 2023;18(1):848.","journal-title":"J Orthop Surg Res"},{"issue":"1","key":"8621_CR55","doi-asserted-by":"publisher","first-page":"4681","DOI":"10.1080\/21655979.2021.1957754","volume":"12","author":"Y Yu","year":"2021","unstructured":"Yu Y, et al. Inhibin \u03b2-A (INHBA) induces epithelial-mesenchymal transition and accelerates the motility of breast cancer cells by activating the TGF-\u03b2 signaling pathway. Bioengineered. 2021;12(1):4681\u201396.","journal-title":"Bioengineered"},{"key":"8621_CR56","doi-asserted-by":"publisher","first-page":"153303382412347","DOI":"10.1177\/15330338241234798","volume":"23","author":"Z Wu","year":"2024","unstructured":"Wu Z, et al. Elevated INHBA Promotes Tumor Progression of Cervical Cancer. Technol Cancer Res Treat. 2024;23:15330338241234798.","journal-title":"Technol Cancer Res Treat"},{"issue":"6","key":"8621_CR57","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrneph.2016.48","volume":"12","author":"XM Meng","year":"2016","unstructured":"Meng XM, Nikolic-Paterson DJ, Lan HY. TGF-\u03b2: the master regulator of fibrosis. Nat Rev Nephrol. 2016;12(6):325\u201338.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"8621_CR58","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/cr.2008.328","volume":"19","author":"YE Zhang","year":"2009","unstructured":"Zhang YE. Non-Smad pathways in TGF-beta signaling. Cell Res. 2009;19(1):128\u201339.","journal-title":"Cell Res"},{"key":"8621_CR59","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cytogfr.2025.05.004","volume":"85","author":"W Luo","year":"2025","unstructured":"Luo W, et al. TGF-\u03b2-driven EMT in cancer progression and drug resistance. Cytokine Growth Factor Rev. 2025;85:11\u201325.","journal-title":"Cytokine Growth Factor Rev"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08621-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08621-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08621-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:17:45Z","timestamp":1791332265000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08621-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8621"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08621-0","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]},"assertion":[{"value":"26 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the Fifth Clinical Medical College of Shanxi Medical University (Shanxi Provincial People\u2019s Hospital) (approval No. 591). Written informed consent was obtained from all human participants, and all animal procedures followed the reviewed and approved experimental protocol and animal care plan.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interest.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1254"}}